Omada Health (NASDAQ:OMDA) Upgraded at Wells Fargo & Company

Wells Fargo & Company upgraded shares of Omada Health (NASDAQ:OMDA) to a hold rating in a research note issued to investors on Thursday,Zacks.com reports.

A number of other analysts also recently issued reports on OMDA. The Goldman Sachs Group set a $29.00 price target on shares of Omada Health in a report on Friday. Needham & Company LLC lifted their price target on Omada Health from $26.00 to $28.00 and gave the company a “buy” rating in a research note on Friday, November 7th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Omada Health in a report on Wednesday, October 8th. BMO Capital Markets initiated coverage on Omada Health in a research report on Thursday, November 13th. They issued an “outperform” rating and a $27.00 price objective for the company. Finally, Evercore ISI upped their target price on Omada Health from $27.00 to $28.00 and gave the stock an “outperform” rating in a research note on Friday, November 7th. Eight research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Omada Health has a consensus rating of “Moderate Buy” and an average target price of $25.40.

Omada Health Trading Down 6.3%

Omada Health stock opened at $15.41 on Thursday. The firm has a market cap of $892.39 million and a PE ratio of -61.64. Omada Health has a 12 month low of $14.14 and a 12 month high of $28.40. The stock’s 50 day simple moving average is $17.60 and its two-hundred day simple moving average is $20.05.

Insider Buying and Selling at Omada Health

In other Omada Health news, President Wei-Li Shao sold 5,618 shares of the company’s stock in a transaction on Monday, December 29th. The stock was sold at an average price of $16.13, for a total value of $90,618.34. Following the completion of the sale, the president directly owned 69,079 shares in the company, valued at $1,114,244.27. This represents a 7.52% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Hedge Funds Weigh In On Omada Health

A number of hedge funds have recently made changes to their positions in the stock. Strs Ohio acquired a new stake in Omada Health in the 3rd quarter valued at approximately $38,000. Raymond James Financial Inc. acquired a new stake in shares of Omada Health in the second quarter valued at $32,000. Bellevue Group AG grew its stake in shares of Omada Health by 0.7% in the third quarter. Bellevue Group AG now owns 251,791 shares of the company’s stock valued at $5,567,000 after buying an additional 1,791 shares in the last quarter. Rakuten Investment Management Inc. purchased a new stake in shares of Omada Health in the 3rd quarter valued at $49,000. Finally, JPMorgan Chase & Co. acquired a new position in Omada Health during the 3rd quarter worth about $82,000.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.